Hims & Hers Health Inc. ($HIMS) Stock Forecast: Up 7.2% Today

What is Hims & Hers Health Inc.?

Hims & Hers Health (NYSE: HIMS) specializes in telehealth and wellness products and services. The stock showed a strong bullish movement today amidst recent market volatility.

Why is Hims & Hers Health Inc. going up?

HIMS stock is up 7.2% on Nov 18, 2024 18:07

• The bullish movement in HIMS stock could be linked to the interest of deep-pocketed investors in the company, as shown by significant options trading trends favoring Hims & Hers Health.
• Though there was a recent decrease in stock price over the past month, the notable increase in the stock price over the past year may have boosted investor confidence, leading to today's spike.
• The negative reaction to a competitor's new upfront pricing for telehealth services may have initially caused a dip in HIMS stock. However, the subsequent recovery and bullish movement suggest that investors are more focused on the company's growth potential and product expansions.
• HIMS' initiatives to improve its offerings and expand its health and wellness product range might have positively impacted investor sentiment, overshadowing potential macro challenges that could affect its future performance.

HIMS Price Chart

HIMS Technical Analysis

HIMS News

Unpacking the Latest Options Trading Trends in Hims & Hers Health - Hims & Hers Health ( NYSE:HIMS )

Deep-pocketed investors have adopted a bullish approach towards Hims & Hers Health HIMS, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.

https://www.benzinga.com/insights/options/24/11/42041652/unpacking-the-latest-options-trading-trends-in-hims-hers-health

Price Over Earnings Overview: Hims & Hers Health - Hims & Hers Health ( NYSE:HIMS )

In the current market session, Hims & Hers Health Inc. HIMS share price is at $19.85, after a 2.74% spike. Moreover, over the past month, the stock decreased by 18.10%, but in the past year, increased by 154.88%.

https://www.benzinga.com/insights/news/24/11/42034311/price-over-earnings-overview-hims-hers-health

Hims & Hers Health Stock Is Tumbling Thursday: What's Going On? - Hims & Hers Health ( NYSE:HIMS )

Hims & Hers Health Inc HIMS shares are trading lower in possible response to Amazon.com Inc's AMZN new upfront pricing for telehealth visits and treatment plans.

https://www.benzinga.com/trading-ideas/movers/24/11/41977650/hims-hers-health-stock-is-tumbling-thursday-whats-going-on

Hims & Hers Stock Gains 31.1% Since Q3 Earnings: What's Next?

HIMS is enhancing its offerings and expanding the breadth of health and wellness products and services. However, macro challenges are likely to hurt its performance.

https://www.zacks.com/stock/news/2369800/hims-hers-stock-gains-311-since-q3-earnings-whats-next

Unpacking the Latest Options Trading Trends in Hims & Hers Health - Hims & Hers Health ( NYSE:HIMS )

Investors with a lot of money to spend have taken a bullish stance on Hims & Hers Health HIMS. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.

https://www.benzinga.com/insights/options/24/11/41909877/unpacking-the-latest-options-trading-trends-in-hims-hers-health

Trending Today

Virgin Galactic Holdings Inc ($SPCE) Stock Forecast: Up 5.1% Today

Foot Locker Inc. ($FL) Stock Forecast: Up 5.1% Today

Grab Holdings Limited ($GRAB) Stock Forecast: Down 6.3% Today

Kohl's Corporation ($KSS) Stock Forecast: Up 5.6% Today

Sirius XM Holdings Inc. ($SIRI) Stock Forecast: Up 5.0% Today

lululemon athletica inc. ($LULU) Stock Forecast: Up 5.2% Today

Teladoc Health Inc. ($TDOC) Stock Forecast: Up 11.7% Today

Macy's Inc ($M) Stock Forecast: Up 7.2% Today

Cytokinetics, Incorporated ($CYTK) Stock Forecast: Down 5.2% Today

Gap Inc. ($GAP) Stock Forecast: Up 15.9% Today

Hims & Hers Health Inc. Price History

01.10.2024 - HIMS Stock was up 6.9%

• The third-quarter performance of Hims & Hers Health, Inc. was likely boosted by the increasing adoption of its offerings and the growth of its subscriber base, contributing to the recent bullish movement.
• Although there was a minor -1.1% fluctuation in the stock price in the last trading session, the overall market sentiment remained positive, emphasizing the company's growth potential over this temporary dip.
• Initial concerns may have arisen following an FDA update featuring Novo Nordisk's medications Ozempic and Wegovy, which potentially impacted the stock price briefly. However, investor confidence seems to have been restored since then.
• The bullish movement might also be linked to significant investments in HIMS options by institutional investors and high-net-worth individuals, suggesting a favorable outlook among this demographic.

01.10.2024 - HIMS Stock was up 5.6%

• The stock of HIMS showed strong bullish momentum today, despite a -1.1% change in the closing of the recent trading day.
• An FDA update listing Novo Nordisk's diabetes drug Ozempic and weight-loss drug Wegovy as available potentially influenced some volatility in the stock price.
• Some investors took a bearish stance on HIMS options, possibly leading to market uncertainties, although the general sentiment towards the company remained positive.
• Anticipation of Hims & Hers Health's earnings growth could have contributed to the bullish movement as investors expect favorable financial results in the upcoming period.

18.10.2024 - HIMS Stock was up 5.4%

• The bullish movement in HIMS stock could be attributed to the company's efforts to enhance its offerings and expand its health and wellness products and services.
• The positive sentiment towards HIMS could also be influenced by the bullish stance taken by investors with significant capital.
• The stock might have also benefited from the overall market optimism or specific sector trends, despite potential macro challenges that could impact its performance.
• The dip in HIMS stock price due to Amazon's new pricing strategy for telehealth services might have been overshadowed by the positive developments and investor sentiment, leading to the overall bullish movement.

18.10.2024 - HIMS Stock was up 7.2%

• The bullish movement in HIMS stock could be linked to the interest of deep-pocketed investors in the company, as shown by significant options trading trends favoring Hims & Hers Health.
• Though there was a recent decrease in stock price over the past month, the notable increase in the stock price over the past year may have boosted investor confidence, leading to today's spike.
• The negative reaction to a competitor's new upfront pricing for telehealth services may have initially caused a dip in HIMS stock. However, the subsequent recovery and bullish movement suggest that investors are more focused on the company's growth potential and product expansions.
• HIMS' initiatives to improve its offerings and expand its health and wellness product range might have positively impacted investor sentiment, overshadowing potential macro challenges that could affect its future performance.

30.09.2024 - HIMS Stock was down 16.9%

• Smart money investors have shown bearish sentiments towards HIMS options.
• Earnings expectations for Hims & Hers Health are not very upbeat, reducing the possibility of an earnings beat.
• The bearish options trading and subdued earnings outlook may have led to the significant bearish movement in HIMS stock today.

13.10.2024 - HIMS Stock was up 5.3%

• HIMS stock has shown significant gains since the Q3 earnings report, signaling favorable investor sentiment and confidence in the company's growth prospects.
• The rise in earnings estimates indicates investor optimism about the company's future performance, driving a bullish trend in the stock.
• Deep-pocketed investors' bullish stance on HIMS options has further bolstered the stock's positive momentum, showcasing strong support for the company's potential.
• The bullish movement in HIMS stock is attributed to the company's strategic initiatives to enhance its offerings and expand its product range, despite potential macro challenges that could impact its performance.

31.09.2024 - HIMS Stock was down 10.7%

• The bearish movement in HIMS stock today could be related to an FDA update mentioning the availability of Novo Nordisk's diabetes drug Ozempic and weight-loss drug Wegovy, which could impact Hims & Hers Health's market share and competitiveness in the health sector.
• The increase in bearish options trading on HIMS suggests that investors with substantial capital have a negative outlook on the stock, possibly due to concerns about the company's future performance or market conditions.
• The lack of positive expectations for Hims & Hers Health's upcoming earnings report may have also influenced the stock price decline, with investors adjusting their positions based on anticipated financial results.

11.10.2024 - HIMS Stock was up 6.1%

• HIMS stock saw a bullish trend today.
• Solid earnings forecast revisions and robust third-quarter performance were key drivers behind this positive market sentiment.
• Increased options trading activity by savvy investors suggests optimism surrounding HIMS stock.
• The company's emphasis on telehealth service expansion and raised full-year revenue forecast are likely fueling the stock's positive trajectory.

14.10.2024 - HIMS Stock was down 18.6%

• The stock's downturn today may be linked to Amazon.com Inc's introduction of fixed pricing for telehealth services, signaling potential competition concerns in the industry.
• Despite HIMS broadening its offerings and product range, it faces broader economic headwinds that could detract from its performance, influencing the negative stock trend.
• Ongoing bullish options trading on HIMS could reflect mixed investor sentiment, with some optimistic and others more cautious, resulting in heightened volatility and downward pressure on the stock.
• Positive revisions in earnings outlook for HIMS hint at long-term growth prospects. However, short-term market conditions and external factors are currently driving down the stock despite these positive forecasts.

05.10.2024 - HIMS Stock was up 5.0%

• Strong third-quarter results were reported by Hims & Hers Health, surpassing earnings per share expectations at 32 cents.
• The company also revised its full-year revenue forecast upwards, signaling promising growth prospects.
• Bullish options activity by well-funded investors reflects confidence in the company's future performance.
• The favorable earnings report and optimistic market sentiment are key factors likely driving the bullish trend in HIMS stock today.

07.10.2024 - HIMS Stock was up 5.0%

• Significant interest from institutional investors in HIMS options suggests a strong positive sentiment and confidence in the company's future.
• Hims & Hers Health posted robust third-quarter results and raised its full-year revenue guidance, leading to a boost in investor confidence and pushing up the stock price.
• The company exceeded expectations with third-quarter earnings per share reaching 32 cents, surpassing estimates and contributing to the bullish trend.
• The combination of positive earnings results, increased revenue outlook, and active trading in bullish options likely drove the sharp uptick in Hims & Hers Health stock today.

12.10.2024 - HIMS Stock was down 5.7%

• Despite optimistic positions from investors holding substantial Hims & Hers Health options, the market movement did not align positively with these stances, revealing a disparity between options trading patterns and stock behavior.
• Strong revisions in earnings estimates suggested a favorable future outlook, yet the stock followed a bearish trajectory, underscoring the volatile nature of the market.
• The significant interest in HIMS options by well-funded investors did not offset the market's bearish trend, underscoring how wider market sentiments can impact individual stock performance.